Sidney kimmel Cancer Center

Philadelphia, Pennsylvania 19107-4307

6 studies enrolling now · 9 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Breast Cancer, Carcinoma Transitional Cell, Carcinoma in Situ, Extensive Stage Small Cell Lung Cancer, KRAS-mutant Colorectal Cancer (CRC), KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), Locally Advanced Solid Tumor, Metastatic Cancer, Metastatic Solid Tumor

Studies at this site

• A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors — Recruiting now
• A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours — Recruiting now
• An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — Recruiting now
• A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation — Recruiting now
• A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311) — Recruiting now
• A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 — Recruiting now
• Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) — Completed
• A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) — Stopped early
• A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors — Completed